Codex DNA Inc reports results for the quarter ended in June - Earnings Summary

Telesis Bio

10/08/2021 23:14

* Codex DNA Inc  DNAY.OQ  reported a quarterly adjusted loss of
$1.06​​ per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 35
cents per share.
* Revenue was $2.85 million​;  analysts expected $2.55 million. 
* Codex DNA Inc's reported EPS for the quarter was a loss of
$1.06​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Codex DNA Inc shares had fallen by 32.0% this quarter.
* The company reported a quarterly loss of $9.2 million.
* Wall Street's median 12-month price target for Codex DNA Inc
is $26.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 10:14 p.m.  ​All
figures in US dollars unless otherwise stated